| Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. |
2020-02-18 |
| OncoDNA S.A.. (2/14/20). "Press Release: OncoDNA Closes Successful Series B Investment Round". Gosselies. |
2020-02-14 |
| Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. |
2020-02-06 |
| Catalent, Inc.. (2/3/20). "Press Release: Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform". Somers, NJ & Gosselies. |
2020-02-03 |
| Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. |
2020-02-03 |
| Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. |
2020-02-03 |
| iTeos Therapeutics S.A.. (1/30/20). "Press Release: iTeos Therapeutics Awarded €15 Million in Non-Dilutive Funding by the Walloon Region". Gosselies & Cambridge, MA. |
2020-01-30 |
| Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. |
2020-01-23 |
| iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. |
2020-01-23 |
| PDC*line Pharma S.A.. (1/22/20). "Press Release: PDC*line Pharma Raises €20 million in Series B Financing Round". Liège & Grenoble. |
2020-01-22 |
| Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. |
2020-01-20 |
| Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. |
2020-01-16 |
| Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto. |
2020-01-15 |
| Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. |
2020-01-14 |
| ProBioGen AG. (1/14/20). "Press Release: ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule". Berlin & Utrecht. |
2020-01-14 |
| Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. |
2020-01-14 |
| Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. |
2020-01-13 |
| Galapagos N.V.. (1/13/20). "Press Release: Galapagos Completes Recruitment of PINTA Trial in Idiopathic Pulmonary Fibrosis". Mechelen. |
2020-01-13 |
| NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. |
2020-01-10 |
| Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. |
2020-01-10 |
| Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. |
2020-01-08 |
| NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. |
2020-01-08 |
| CureVac AG. (1/7/20). "Press Release: CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study". Tübingen & Boston, MA. |
2020-01-07 |
| Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. |
2020-01-07 |
| Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. |
2019-12-19 |
| Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. |
2019-12-17 |
| Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium. |
2019-12-16 |
| Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe |
2019-12-16 |
| Sphingotec GmbH. (12/16/19). "Press Release: Sphingotec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. |
2019-12-16 |
| iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. |
2019-12-12 |
| Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. |
2019-12-10 |
| ImCheck Therapeutics S.A.S.. (12/4/19). "Press Release: ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases". Marseille. |
2019-12-04 |
| Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren. |
2019-12-03 |
| BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. |
2019-12-02 |
| European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". |
2019-11-29 |
| Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. |
2019-11-28 |
| Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. |
2019-11-27 |
| Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". |
2019-11-20 |
| Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. |
2019-11-20 |
| Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. |
2019-11-19 |
| Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. |
2019-11-19 |
| Qiagen N.V.. (11/15/19). "Press Release: Qiagen Receives Several Conditional, Non-binding Indications of Interest, Enters into Discussions to Explore Potential Strategic Alternatives". Venlo. |
2019-11-15 |
| Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam. |
2019-11-12 |
| [iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. |
2019-11-11 |
| Argenx SE. (11/8/19). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. |
2019-11-08 |
| Argenx SE. (11/7/19). "Press Release: Argenx Raises $484 Million in Gross Proceeds in a Global Offering". Breda & Ghent. |
2019-11-07 |
| Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. |
2019-11-07 |
| Acticor Biotech S.A.S.. (11/6/19). "Press Release: Acticor Biotech Raises €7m in Addition to Its Series B Financing, Now Completed at €22.3m". Paris. |
2019-11-06 |
| Argenx SE. (11/6/19). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. |
2019-11-06 |
| Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
| MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. |
2019-10-28 |
| Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. |
2019-10-28 |
| Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
| Uniqure N.V.. (10/28/19). "Press Release: Uniqure Announces Third Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2019-10-28 |
| Cato Research, LLC. (10/28/19). "Press Release: Cato Research Announces Merger with SMS-Oncology". Durham, NC. |
2019-10-28 |
| OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. |
2019-10-28 |
| Galapagos N.V.. (10/25/19). "Press Release: Galapagos Receives Transparency Notification from Wellington Management Group LLP". Mechelen. |
2019-10-25 |
| Galapagos N.V.. (10/24/19). "Press Release: Solid Third Quarter 2019 Performance with Strong Balance Sheet for Continued R&D Growth". Mechelen. |
2019-10-24 |
| OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. |
2019-10-23 |
| Arnold & Porter LLP. (10/22/19). "Press Release: Life Sciences Lawyer and Former EMA Legal Adviser Alexander Roussanov Joins Arnold & Porter in Brussels". Brussels. |
2019-10-22 |
| Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. |
2019-10-22 |
| Cision Ltd.. (10/22/19). "Press Release: Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion". Chicago. |
2019-10-22 |
| Kiadis Pharma N.V.. (10/17/19). "Press Release: Kiadis Pharma Provides Regulatory Update on ATIR101". Amsterdam. |
2019-10-17 |
| Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris. |
2019-10-17 |
| Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. |
2019-10-16 |
| Gilead Sciences, Inc.. (10/15/19). "Press Release: Gilead Sciences Appoints Andrew Dickinson as Chief Financial Officer". Foster City, CA. |
2019-10-15 |
| UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA. |
2019-10-10 |
| Galapagos N.V.. (10/10/19). "Press Release: Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis". Foster City, CA & Mechelen. |
2019-10-10 |
| N-Side S.A.. (10/9/19). "Press Release: N-Side Welcomes Wade Wirta as US Managing Director". Louvain-la-Neuve. |
2019-10-09 |
| Bluebee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk. |
2019-10-09 |
| Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. |
2019-10-07 |
| Qiagen N.V.. (10/7/19). "Press Release: Qiagen Announces CEO Leadership Transition. Peer M. Schatz to Step Down as CEO to Pursue New Opportunities". Venlo. |
2019-10-07 |
| Illumina, Inc.. (10/7/19). "Press Release: Illumina and Qiagen Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests". San Diego, CA & Hilden & Germantown, MD. |
2019-10-07 |
| Immunexpress, Inc.. (10/3/19). "Press Release: Immunexpress Announces Closing of Private Funding Round". Seattle, WA. |
2019-10-03 |
| Univercells S.A.. (10/3/19). "Press Release: Univercells Boosted by EUR 20m European Financing to Accelerate the Delivery of Its Vaccine Portfolio". Brussels. |
2019-10-03 |
| N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve. |
2019-10-01 |
| Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY. |
2019-10-01 |
| BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". |
2019-09-27 |
| Galapagos N.V.. (9/24/19). "Press Release: Galapagos Initiates Phase 1 Trial for Second Toledo Compound". Mechelen. |
2019-09-24 |
| Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". |
2019-09-20 |
| Novigenix S.A.. (9/19/19). "Press Release: Novigenix and BioLizard Sign Collaboration Agreement for Development of NGS Based Diagnostic Algorithm". Lausanne. |
2019-09-19 |
| Menarini Silicon Biosystems S.p.A.. (9/19/19). "Press Release: Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee". Bologna. |
2019-09-19 |
| ESMO. (9/18/19). "Press Release: Electronic Nose Can Sniff Out Which Lung Cancer Patients Will Respond to Immunotherapy [Annals of Oncology Press Release]". |
2019-09-18 |
| Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich. |
2019-09-18 |
| Celyad S.A.. (9/16/19). "Press Release: Celyad Announces Closing of $20 Million Global Offering". Mont-Saint-Guibert. |
2019-09-16 |
| Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. |
2019-09-16 |
| Immunexpress, Inc.. (9/11/19). "Press Release: Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations". Seattle, WA. |
2019-09-11 |
| Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam. |
2019-09-10 |
| Pharvaris B.V.. (9/10/19). "Press Release: Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema". Leiden. |
2019-09-10 |
| Uniqure N.V.. (9/5/19). "Press Release: Uniqure Announces Pricing of its Public Offering". Lexington, MA & Amsterdam. |
2019-09-05 |
| iStar Medical S.A.. (9/5/19). "Press Release: iStar Medical Announces EUR 40m Series C Financing". Wavre. |
2019-09-05 |
| Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. |
2019-09-04 |
| Uniqure N.V.. (9/4/19). "Press Release: Uniqure Announces Proposed Public Offering". Lexington, MA & Amsterdam. |
2019-09-04 |
| Uniqure N.V.. (9/3/19). "Press Release: Uniqure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B". Lexington, MA & Amsterdam. |
2019-09-03 |
| Achilles Therapeutics. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. |
2019-09-03 |
| Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf. |
2019-08-29 |
| Galapagos N.V.. (8/28/19). "Press Release: Transparency Notification – Gilead Holds 22% of Galapagos Shares". Mechelen. |
2019-08-28 |
| Galapagos N.V.. (8/23/19). "Press Release: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration". Foster City, CA & Mechelen. |
2019-08-23 |
| Uniqure N.V.. (8/20/19). "Press Release: Uniqure Announces Leadership Promotions and Executive Transition". Lexington, MA & Amsterdam. |
2019-08-20 |
| Galapagos N.V.. (8/15/19). "Press Release: European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis". Foster City, CA & Mechelen. |
2019-08-15 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
